A new bill introduced Friday in the U.S. House of Representatives would require new drugs, and certain generic drugs, to have tamper-resistant formulas, ABC News reports. The proposed legislation is designed to reduce prescription drug abuse.
The Food and Drug Administration told lawmakers this month that the process of reclassifying hydrocodone combination products, in order to make them more difficult to prescribe, will be long, The Hill reports.
The group representing the nation’s attorneys general is calling on the Food and Drug Administration to require manufacturers and marketers of generic prescription pain drugs to develop versions of their products that are resistant to tampering and abuse.
Addiction treatment methods in some parts of the world are harsh and unhelpful, according to a new report from the United Nations. Some practices are “tantamount to torture or cruel, inhuman or degrading treatment,” the report states.
Kentucky Governor Steve Beshear approved legislation this week that modifies the state’s new prescription drug law, to make it easier for patients in hospitals, nursing homes and hospice centers to receive painkillers.
Heroin use is on the rise in Missouri, according to a new report to be released Tuesday. Many people using heroin have switched from more expensive opioid pills, according to The Kansas City Star.
There is disagreement among doctors about the best way to prevent prescription painkiller abuse, sometimes even among physicians in the same hospital, according to The Plain Dealer. The Cleveland Clinic is among the institutions where colleagues disagree on the best approach to the problem.
The Food and Drug Administration informed the maker of the opioid addiction treatment Suboxone that it has approved two generic versions of the drug, according to Reuters. The company, Reckitt Benckiser, had asked the agency to block the generic products because of concerns over pediatric poisonings.
Substance abuse prevention programs that begin in middle school may help deter prescription drug abuse in later years, new research suggests.
A new study finds racial differences in opioid prescribing, monitoring and follow-up treatment practices. Black patients are less likely than white patients to have their pain levels documented, and to be referred to a pain specialist. They are more likely to be referred for substance abuse assessment after being prescribed opioids, MedicalXpress reports.
Reproduction in whole or in part of this publication is strictly prohibited without prior consent. Photographic rights remain the property of Join Together and the Partnership for Drug-Free Kids. For reproduction inquiries, please e-mail firstname.lastname@example.org.